# Reducing Drug Harm – Pre-applications Phase 1

**Funder:** ZonMw
**Budget:** Up to €1,067,737.75 per pre-proposal (phase 1); €4,270,951 total for joint application (phase 2)
**Deadline:** 7 July 2026 (Phase 1 pre-proposal deadline; Phase 2 full application deadline 30 March 2027)
**Duration:** Up to 5 years
**Consortium:** Required — minimum main applicant, co-applicant, and cooperation partner
**Application:** 2-stage: Phase 1 pre-proposal (deadline 7 July 2026) → Phase 2 full application via synergy workshops (deadline 30 March 2027)
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.zonmw.nl/en/subsidy/reducing-drug-harm-pre-applications-phase-1
**Last updated:** 6 Sept 2026

## Eligibility & scope

Open to Dutch knowledge institutions, societal organisations and citizens jointly developing research on drug(-related) harm reduction. Consortium required (main applicant + co-applicant + cooperation partner). Main applicant of selected pre-proposals must participate in all phase 2 synergy workshops (Nov 2026–Feb 2027) to submit the joint full proposal. Applications via Mijn ZonMw only.

## Summary

ZonMw's Reducing Drug Harm, Pre-applications Phase 1 funds Dutch multi-sector consortia to develop research on drug-related harm reduction over up to five years. The call requires a mandatory consortium of at least a main applicant, co-applicant, and cooperation partner from knowledge institutions, societal organisations, and citizen groups working together. Selected pre-proposals advance to Phase 2 synergy workshops (November 2026, February 2027), where teams refine their full application for the final March 2027 deadline.

## Who should apply

- Dutch academic, research, or knowledge institutions as lead or co-applicants
- Societal organisations and citizen groups with lived expertise in drug-related harm
- Consortia with representation across academic, civil society, and community perspectives
- Teams ready to participate in in-person synergy workshops November 2026, February 2027

## Key dates

- Phase 1 pre-proposal deadline: 7 July 2026 (closes in 2 days)
- Phase 2 synergy workshops: November 2026, February 2027 for selected pre-proposals
- Phase 2 full application deadline: 30 March 2027

## Tips for applicants

- A consortium without genuine co-design between academic and citizen groups will score poorly; evidence of prior collaboration or co-authored planning documents strengthens Phase 1 credibility.
- The pre-proposal is your gate: clarity on team roles and the harm-reduction research question matters more than elaborate methods at Phase 1.
- If selected, attendance at all synergy workshops is mandatory for the main applicant; plan resource allocation and travel now, as these sessions reshape proposals ahead of Phase 2 submission.

## Frequently asked questions

### What is the budget for ZonMw Reducing Drug Harm?

Phase 1 pre-proposals may request up to €1,067,737.75 each. Selected consortia submit full Phase 2 applications with a total joint budget of up to €4,270,951.

### Is a consortium required for this ZonMw call?

Yes, a mandatory minimum consortium of a main applicant, co-applicant, and cooperation partner is required. Representation should span knowledge institutions, societal organisations, and citizen groups.

### What happens if my pre-proposal is selected?

Selected main applicants must participate in all ZonMw synergy workshops from November 2026 to February 2027, where consortia collaborate to refine and jointly develop their full Phase 2 proposal.

### When is the Phase 2 full application deadline?

The Phase 2 full application deadline is 30 March 2027. Only pre-proposals selected at Phase 1 (7 July 2026) are eligible to proceed.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/zonmw-reducing-drug-harm-pre-applications-phase-1-2026-07) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=zonmw-reducing-drug-harm-pre-applications-phase-1-2026-07).